Tag Archives: Institute of Neuroscience and Physiology: Sahlgrenska Academy at University of Gothenburg

Nutritional Intervention to Slow Dementia Progression?: Evidence Still Unclear on Nutricia’s Souvenaid Drink (BBC News / Lancet Neurology / NHS Choices)

Posted on November 3, 2017 by Dementia and Elderly Care News

Summary A LipiDiDiet trial investigated the effects of Fortasyn Connect on cognitive decline (and related measures) in the early stages of Alzheimer’s Disease. This small trial indicates that Nutricia’s nutrient drink Souvenaid has no significant effect on the rate of … Continue reading →

Posted in BBC News, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Non-Pharmacological Treatments, Nutrition, Pharmacological Treatments, Quick Insights, Universal Interest | Tagged Alzheimer Center Limburg: University of Maastricht, Alzheimer Center: VU University Medical Center, Alzheimer's and Dementia: The Journal of the Alzheimer's Association, Alzheimer's and Dementia: Translational Research and Clinical Interventions (TRCI), Alzheimer’s and Dementia (Journal), Amsterdam Neuroscience: VU University Medical Center, BBC Health News, Behind the Headlines, Care Sciences and Society: Karolinska Institute, Clinical Neurochemistry Laboratory: Sahlgrenska University Hospital, Clinical Trials Unit: Karolinska University Hospital, Cognitive Impairment, Conversion to Dementia From Prodromal Disease, Department of Clinical Geriatrics: Karolinska Institute, Department of Experimental Neurology: Saarland University, Department of Geriatric Medicine: Karolinska University Hospital, Department of Neurobiology: Karolinska Institute, Department of Neurology: Kuopio University Hospital, Department of Neurology: University of Eastern Finland, Department of Neurology: VU University Medical Center, Department of Psychiatry and Neurochemistry: Sahlgrenska Academy at University of Gothenburg, Department of Psychiatry and Neuropsychology: University of Maastricht, European Commission 7th Framework Programme, European Community’s Seventh Framework Programme, Fatty Acids, Finland, Fortasyn Connect, German Institute for Dementia Prevention (DIDP), Germany, Improving Nutritional Care, Institute of Clinical Medicine: University of Eastern Finland, Institute of Neuroscience and Physiology: Sahlgrenska Academy at University of Gothenburg, Karolinska Institutet, Karolinska Institutet (Stockholm), Karolinska University Hospital, Kuopio University Hospital, Lancet Neurology, LipiDiDiet Trial, Medical Faculty: Saarland University, Netherlands, Neuneuropsychological Test Battery (NTB), NeuroCenter Kuopio University Hospital, NL-ENIGMA Trial, Nutricia Advanced Medical Nutrition, Nutricia’s Souvenaid Drink, Nutrients, Nutrition and Dementia, Nutrition Support, Nutritional Approaches to Slowing or Arresting Cognitive Impairment / Dementia, Nutritional Interventions, Nutritional Supplementation, Oral Nutritional Supplements, Pentara Corporation (Salt Lake City), Preclinical Alzheimer's Disease, Preclinical Phase of Dementia, Prodromal Alzheimer's Disease, Saarland University (Homburg), Sahlgrenska Academy: University of Gothenburg, Sahlgrenska University Hospital, Souvenaid Drink (Nutricia), Sweden, University of Eastern Finland, University of Gothenburg, University of Maastricht, USA, Vitamins, VU University Medical Center | Leave a comment

Huntington’s Disease: a Blood Test “Speedometer”? (BBC News / Lancet Neurology)

Posted on June 12, 2017 by Dementia and Elderly Care News

Summary Early research shows promise that a protein biomarker in the blood, called neurofilament light chain (NFL), which is released from damaged brain cells in Huntington’s Disease, may be the basis for a blood test able to predict whether people … Continue reading →

Posted in BBC News, Diagnosis, For Researchers (mostly), In the News, International, Quick Insights, UK, Universal Interest | Tagged BBC Health News, Biomarker Development, Biomarkers, Biomarkers Research Programmes, Blood Tests, Blood-Based Biomarkers, Blood-Based Biomarkers of Pre-Symptomatic Huntington’s Disease, Blood-Based NfL, Canada, Carver College of Medicine: University of Iowa, Cath Stanley: Chief Executive of Hungtington's Disease Association, Centre for Molecular Medicine and Therapeutics: University of British Columbia, CHDI Foundation, Department of Neurology: Leiden University, Department of Psychiatry and Neurochemistry: Sahlgrenska Academy; University of Gothenburg, Department of Psychiatry: University of Iowa, European Research Council, France, Genetics Department: Pitié-Salpêtrière University Hospital, HTT, HTT Mutation Carriers, Huntington Disease, Huntington's Disease Centre: UCL Institute of Neurology, Huntington’s Disease, INSERM, Institut du Cerveau et de la Moelle épinière (ICM), Institute of Neuroscience and Physiology: Sahlgrenska Academy (University of Gothenburg), Institute of Neuroscience and Physiology: Sahlgrenska Academy at University of Gothenburg, Knut and Alice Wallenberg Foundation, Lancet Neurology, Leiden University, Leonard Wolfson Experimental Neurology Centre: University College London, Medical Research Council (MRC), Mutant Huntingtin (mHTT), National Hospital for Neurology and Neurosurgery, National Institute for Health Research UCL Hospitals Biomedical Research Centre, Netherlands, Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurofilament Light Chain (NFL), Neurofilament Light Protein (NF-L), Neurofilament Light Protein in Blood: Potential Biomarker of Huntington's Disease, Neurofilament Light Protein in Blood: Potential Biomarker of Neurodegeneration, Non-Invasive Biomarkers, Pitié-Salpêtrière University Hospital (Paris), Plasma Biomarkers, Plasma Neurofilament Light Chain, Preclinical Biomarkers in Huntington's Disease, Protein-Based Biomarkers in Blood May Deliver Accurate Diagnoses, Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital (Sweden), Serum Neurofilament Light Chain Protein, Sorbonne Universités, Surrogate Biomarkers of Neurodegeneration, Sweden; Clinical Neurochemistry Laboratory: Sahlgrenska University Hospital, Swedish Research Council, Torsten Söderberg Foundation, Transforming Research and Clinical Knowledge in Huntington's Disease (TRACK-HD), UCL Institute of Neurology, University College London (UCL), University of British Columbia, University of Gothenburg, University of Iowa, UPMC University Paris 06: INSERM | Leave a comment

Tag Archives: Institute of Neuroscience and Physiology: Sahlgrenska Academy at University of Gothenburg

Nutritional Intervention to Slow Dementia Progression?: Evidence Still Unclear on Nutricia’s Souvenaid Drink (BBC News / Lancet Neurology / NHS Choices)

Huntington’s Disease: a Blood Test “Speedometer”? (BBC News / Lancet Neurology)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites